During the past decade, Lima Memorial Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 132 clinical trials were completed, i.e. on average, 2640% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 32 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lima Memorial Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 72 trials, followed by "National Cancer Institute (NCI)" with 52 trials sponsored, "SWOG Cancer Research Network" with 22 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored and "Radiation Therapy Oncology Group" with 11 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lima Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 139 trials as a collaborator, "NCIC Clinical Trials Group" with 18 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 13 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Lima Memorial Hospital" are "Breast Cancer" (41 trials), "Lung Cancer" (17 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Lymphoma" (8 trials) and "Pain" (7 trials). Many other conditions were trialed in "Lima Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Lima Memorial Hospital" are "Drug" (161 trials), "Other" (92 trials), "Biological" (74 trials), "Radiation" (33 trials) and "Procedure" (21 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "placebo" (33 trials), "Quality-of-Life Assessment" (19 trials), "Bevacizumab" (16 trials) and "bevacizumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "Lima Memorial Hospital" are 147 trials for "All" genders, 40 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Lima Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 131 completed trials in Lima Memorial Hospital, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Lima Memorial Hospital, 8 "Phase 1" clinical trials were conducted, 75 "Phase 2" clinical trials and 102 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".